Enzyme deficiency protects hepatitis C patients from treatment-related anaemia

Many people who undergo treatment for hepatitis C develop haemolytic anaemia, a disorder that destroys red blood cells. In some cases, it is so severe they have to reduce their medication or stop therapy altogether. But now, scientists in Duke University's Institute for Genome Sciences and Policy (IGSP) have discovered two genetic alterations linked to a benign enzyme condition that keep some patients anaemia-free...

Read the whole article on

More from